NOVA1 Antikörper (AA 121-134)
-
- Target Alle NOVA1 Antikörper anzeigen
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Bindungsspezifität
- AA 121-134
-
Reaktivität
- Human, Maus, Ratte, Kaninchen, Rind (Kuh), Hund, Xenopus laevis, Fledermaus, Huhn, Affe, Schwein
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NOVA1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human NOVA1. This antibody is expected to recognise all three reported isoforms (NP_002506.2 , NP_006480.2 , NP_006482.1)
- Homologie
- Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Panda, Dog, Bat, Bovine, Rabbit, Pig, Opossum, Turkey, Chicken, Platypus, Lizard, Xenopus (100%) Horse (86%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide C-REMPQNVAKTEPVS from an internal region of human NOVA1 (NP_002506.2 , NP_006480.2 , NP_006482.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Panda, Dog, Bat, Bovine, Rabbit, Pig, Opossum, Turkey, Chicken, Platypus, Lizard, Xenopus (100%), Horse (86%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product NOVA1 Primärantikörper
-
-
- Applikationshinweise
-
Approved: IHC, IHC-P (2.5 μg/mL), Peptide-ELISA (1:64000), WB (0.01 - 0.03 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 2.5 μg/mL. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Andere Bezeichnung
- NOVA1 (NOVA1 Produkte)
- Synonyme
- Nova-1 antikoerper, NOVA1 antikoerper, si:ch211-222c22.9 antikoerper, 9430099M15Rik antikoerper, G630039L02 antikoerper, NOVA alternative splicing regulator 1 antikoerper, neuro-oncological ventral antigen 1 L homeolog antikoerper, neuro-oncological ventral antigen 1 antikoerper, RNA-binding protein Nova-1 antikoerper, lipid A export ATP-binding/permease protein antikoerper, NOVA1 antikoerper, Nova1 antikoerper, nova1.L antikoerper, nova1 antikoerper, LOC790874 antikoerper, novA1 antikoerper
- Hintergrund
-
Name/Gene ID: NOVA1
Synonyms: NOVA1, Nova-1, Onconeural ventral antigen 1, RNA-binding protein Nova-1, Paraneoplastic Ri antigen - Gen-ID
- 4857
- NCBI Accession
- NP_002506, NP_006480, NP_006482
- UniProt
- P51513
-